In This Article:
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Moderna Inc. (MRNA) on Thursday reported a loss of $971 million in its first quarter.
The Cambridge, Massachusetts-based company said it had a loss of $2.52 per share.
The results topped Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for a loss of $2.92 per share.
The biotechnology company posted revenue of $108 million in the period, falling short of Street forecasts. Eight analysts surveyed by Zacks expected $127 million.
Moderna expects full-year revenue in the range of $1.5 billion to $2.5 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNA at https://www.zacks.com/ap/MRNA